NASDAQ:BLUE

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

For the period August 16–17, 2025, the biotech, pharma, medical, and health sectors saw a range of significant developments worldwide. Below is a comprehensive roundup of top stories categorized by theme, complete with expert insights and source links:

17 August 2025

NASDAQ:BLUE·NASDAQ:CRSP·NASDAQ:GBT·NASDAQ:VRTX·NYSE:MRK·NYSE:PFE·Pharmaceutical News

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

This weekend brought a flurry of significant biotech, pharmaceutical, medical, and health developments worldwide – from game-changing scientific breakthroughs to high-stakes regulatory decisions and industry shake-ups. Below is a comprehensive roundup of the major news from August 9 and 10, 2025, organized by category for easy reading.

10 August 2025

NASDAQ:BLUE·NASDAQ:BNTX·NASDAQ:CVAC·NYSE:BAX·NYSE:PFE·Pharmaceuticals·XETRA:BAYN

Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)

with hormone therapy for metastatic prostate cancer based on positive Phase 3 data onclive.com.)

9 August 2025

Biotechnology·Healthcare News·NASDAQ:BLUE

NASDAQ:BLUE 9 August 2025 - 17 August 2025

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Biotech & Health Bombshells: FDA Greenlights, Clinical Breakthroughs & Global Health Milestones (Aug 8–9, 2025)